Nunzia Pharmaceutical Corp. (NUNZ)
0.0001
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Nunzia Pharmaceutical Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2003 | 38.46% |
| December 31, 2002 | |
| September 30, 2002 | -16.91% |
| June 30, 2002 | 10.41% |
| March 31, 2002 | 20.89% |
| December 31, 2001 | |
| September 30, 2001 |
| Date | Value |
|---|---|
| June 30, 2001 | |
| March 31, 2001 | |
| December 31, 2000 | |
| September 30, 2000 | |
| June 30, 2000 | -496.3% |
| March 31, 2000 | -112.1% |
| December 31, 1999 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Entia Biosciences, Inc. | -- |
| Trident Brands, Inc. | -- |
| Medifast, Inc. | 69.90% |
| Integrated BioPharma, Inc. | 0.29% |
| Skinvisible, Inc. | 0.00% |